CCRN
Cross Country Healthcare Inc.
$13.37
-$0.17(-1.26%)
48
Overall
60
Value
36
Tech
--
Quality
Market Cap
$421.97M
Volume
267.62K
52W Range
$9.58 - $18.33
Target Price
$18.08
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $767.4M | $833.5M | $865.0M | $816.5M | $822.2M | $836.4M | $1.7B | $2.8B | $2.0B | $1.3B | ||
| Total Revenue | $767.4M | $833.5M | $865.0M | $816.5M | $822.2M | $836.4M | $1.7B | $2.8B | $2.0B | $1.3B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-570.1M | $-611.8M | $636.5M | $609.5M | $618.0M | $633.7M | $1.3B | $2.2B | $1.6B | $1.1B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $197.4M | $220.9M | $228.5M | $207.0M | $204.2M | $202.7M | $375.0M | $627.7M | $450.4M | $274.3M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $170.3M | $189.6M | $199.4M | $194.2M | $198.0M | $189.5M | $229.9M | $337.5M | $333.2M | $273.0M | ||
| Selling, General & Administrative | $161.3M | $179.8M | $187.4M | $180.2M | $184.0M | $176.8M | $220.1M | $334.5M | $314.9M | $254.8M | ||
| Selling & Marketing Expenses | $161.3M | $179.8M | $187.4M | $180.2M | $7.9M | $6.2M | $9.5M | $16.1M | $11.5M | $8.5M | ||
| General & Administrative Expenses | $-8.1M | $-8.4M | $-9.4M | $-9.3M | $184.0M | $176.8M | $220.1M | $334.5M | $314.9M | $254.8M | ||
| Promotion & Advertising | $-4.9M | $-10.2M | -- | $-6.7M | $7.9M | $6.2M | $9.5M | -- | -- | -- | ||
| Salaries & Wages | $-2.5M | $-3.4M | $-4.1M | $-3.6M | -- | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $8.1M | $9.2M | $10.2M | $11.8M | $14.1M | $12.7M | $9.9M | $12.6M | $18.3M | $18.2M | ||
| Depreciation & Amortization | $8.1M | $9.2M | $10.2M | $11.8M | $14.1M | $12.7M | $9.9M | $12.6M | $18.3M | $18.2M | ||
| Amortization | $4.2M | $5.0M | -- | -- | $101.1M | $90.9M | $119.5M | $163.3M | $135.4M | $135.1M | ||
| Other Operating Expenses | $999.0K | $593.0K | $1.8M | $2.2M | $-1.3M | $-974.0K | $-1.9M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $27.0M | $31.3M | $29.1M | $12.8M | $-15.7M | $-9.2M | $139.3M | $273.1M | $112.7M | $-16.9M | ||
| EBITDA | $20.9M | $21.6M | $19.3M | $-313.0K | $-4.8M | $3.2M | $149.9M | $283.3M | $129.3M | $4.0M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $6.8M | $6.1M | $4.2M | $5.7M | $5.3M | $2.9M | $6.9M | $14.4M | $8.1M | $2.2M | ||
| Interest Income Operating | -- | $3.4M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Intinc | -- | -- | -- | $400.0K | $200.0K | -- | -- | -- | $83.0K | $2.0M | ||
| Net Non-Operating Interest Income/Expense | $-6.8M | $-6.1M | $-4.2M | $-5.7M | $-5.3M | $-2.9M | $-6.9M | $-14.4M | $-8.0M | $-138.0K | ||
| Gain on Sale of Securities | -- | -- | -- | -- | $-1.3M | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $12.7M | $-4.4M | $5.2M | $152.0K | $3.2M | $280.0K | $-770.0K | $-19.5M | $1.8M | $-605.0K | ||
| Other Special Charges | $306.0K | $-1.3M | $-3.2M | $339.0K | $-1.9M | $-280.0K | $770.0K | $-2.4M | $-1.8M | $605.0K | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $1.3M | $753.0K | $1.0M | $2.8M | $3.6M | $6.1M | $2.6M | $1.9M | $2.6M | $4.3M | ||
| Special Income Charges | $-3.4M | $-25.1M | $-15.4M | $-25.2M | $-21.5M | $-22.3M | $-4.7M | $-7.5M | $-3.3M | $-7.2M | ||
| Impairment of Capital Assets | $2.1M | $24.3M | $14.4M | $22.4M | $16.3M | $16.2M | $2.1M | $5.6M | $719.0K | $2.9M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $11.0M | $10.7M | $8.5M | $-12.5M | $-18.9M | $-9.4M | $140.1M | $270.7M | $111.0M | $-14.2M | ||
| Pre-Tax Income | $4.2M | $4.5M | $4.3M | $-18.2M | $-24.2M | $-12.3M | $133.2M | $256.3M | $102.9M | $-16.4M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-794.0K | $-4.2M | $-34.5M | $-2.5M | $31.7M | $-188.0K | $1.2M | $67.9M | $30.3M | $-1.8M | ||
| NET INCOME | ||||||||||||
| Net Income | $4.4M | $8.0M | $37.5M | $-17.0M | $-57.7M | $-13.0M | $132.0M | $188.5M | $72.6M | $-14.6M | ||
| Net Income (Continuing Operations) | $4.4M | $8.0M | $37.5M | $-17.0M | $-57.7M | $-13.0M | $132.0M | $188.5M | $72.6M | $-14.6M | ||
| Net Income (Discontinued Operations) | $4.4M | $8.0M | $37.5M | $-17.0M | $-57.7M | $-13.0M | $132.0M | $188.5M | $72.6M | $-14.6M | ||
| Net Income (Common Stockholders) | $4.4M | $8.0M | $37.5M | $-17.0M | $-57.3M | $-13.0M | $132.0M | $188.5M | $72.6M | $-14.6M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-399.7M | $-422.2M | $835.9M | $803.7M | $816.1M | $823.1M | $1.5B | $2.5B | $1.9B | $1.3B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $31.5M | $32.1M | $35.0M | $35.7M | $35.8M | $36.1M | $36.7M | $37.0M | $35.2M | $33.4M | ||
| Average Shares Outstanding (Diluted) | $32.2M | $36.2M | $36.2M | $35.7M | $35.8M | -- | $37.4M | $37.5M | $35.5M | $33.4M | ||
| Shares Outstanding | $32.6M | $33.0M | $36.4M | $36.1M | $36.9M | $37.5M | $38.1M | $36.8M | $34.7M | $32.8M | ||
| Basic EPS | $0.14 | $0.25 | $1.07 | $-0.48 | $-1.61 | $-0.36 | $3.6 | $5.09 | $2.07 | $-0.44 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-1.61 | $-0.36 | $3.6 | $5.09 | $2.07 | $-0.44 | ||
| Diluted EPS | $0.14 | $0.15 | $1.01 | $-0.48 | $-1.61 | $-0.36 | $3.53 | $5.02 | $2.05 | $-0.44 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-1.61 | -- | $3.53 | $5.02 | $2.05 | $-0.44 | ||
| OTHER METRICS | ||||||||||||
| Acquired In Process Rn D | $-9.9M | -- | $1.6M | -- | -- | -- | -- | -- | -- | -- | ||
| Acquired In Process Rn D Income | $-9.9M | $5.8M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Acquisition Expense | -- | -- | -- | -- | $311.0K | -- | -- | -- | -- | -- | ||
| Gain On Sale Of Business | $-2.2M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | $-536.0K | $-764.0K | $-1.3M | $-1.2M | $-1.8M | $-820.0K | $-324.0K | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | $1.6M | -- | -- | -- | $1.1M | -- | ||
| Other Gand A | $-8.1M | $-8.4M | $-9.4M | $-9.3M | $184.0M | $176.8M | $220.1M | $334.5M | $314.9M | $254.8M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | $4.5M | $1.7M | -- | -- | -- | ||
| Realized Capital Gain | -- | $5.8M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $-8.1M | $-8.4M | $-9.4M | $-9.3M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $161.3M | $179.8M | $187.4M | $180.2M | -- | -- | -- | -- | -- | -- | ||
| Write Down | $-9.9M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | $1.3M | $753.0K | $1.0M | $2.8M | $3.6M | $6.1M | $2.6M | $1.9M | $2.6M | $4.3M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CCRN | $13.37 | -1.3% | 267.62K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cross Country Healthcare Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW